{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:43:56Z","timestamp":1791297836473,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T00:00:00Z","timestamp":1460073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.celrep.2016.04.029","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T13:32:08Z","timestamp":1462023128000},"page":"1144-1160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":213,"title":["Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling"],"prefix":"10.1016","volume":"15","author":[{"given":"Elizabeth","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Mi\u00e9ville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen\u00a0M.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadegh","family":"Saghafinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Wen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Hanahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2016.04.029_bib1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nrc2442","article-title":"Modes of resistance to anti-angiogenic therapy","volume":"8","author":"Bergers","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2016.04.029_bib2","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.284.5415.808","article-title":"Effects of angiogenesis inhibitors on multistage carcinogenesis in mice","volume":"284","author":"Bergers","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.celrep.2016.04.029_bib3","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1172\/JCI200317929","article-title":"Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors","volume":"111","author":"Bergers","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2016.04.029_bib4","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1101\/gad.1256804","article-title":"Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex","volume":"18","author":"Brugarolas","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2016.04.029_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","article-title":"Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors","volume":"8","author":"Casanovas","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2016.04.029_bib6","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1200\/JCO.2010.28.0198","article-title":"Survival benefit with proapoptotic molecular and pathologic responses from dual targeting of mammalian target of rapamycin and epidermal growth factor receptor in a preclinical model of pancreatic neuroendocrine carcinogenesis","volume":"28","author":"Chiu","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.celrep.2016.04.029_bib7","doi-asserted-by":"crossref","first-page":"17268","DOI":"10.1073\/pnas.1012705107","article-title":"Polymorphic genetic control of tumor invasion in a mouse model of pancreatic neuroendocrine carcinogenesis","volume":"107","author":"Chun","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2016.04.029_bib8","first-page":"253","article-title":"Understanding and targeting resistance to anti-angiogenic therapies","volume":"4","author":"Clarke","year":"2013","journal-title":"J.\u00a0Gastrointest. Oncol."},{"key":"10.1016\/j.celrep.2016.04.029_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.gde.2012.12.005","article-title":"mTOR in aging, metabolism, and cancer","volume":"23","author":"Cornu","year":"2013","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.celrep.2016.04.029_bib10","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.cub.2014.08.007","article-title":"The mTORC1\/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation","volume":"24","author":"Csibi","year":"2014","journal-title":"Curr. Biol."},{"key":"10.1016\/j.celrep.2016.04.029_bib11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1242\/dmm.007724","article-title":"Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments","volume":"4","author":"Draoui","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.celrep.2016.04.029_bib12","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1158\/1535-7163.MCT-13-0653","article-title":"Antitumor activity of 7-aminocarboxycoumarin derivatives, a new class of potent inhibitors of lactate influx but not efflux","volume":"13","author":"Draoui","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.celrep.2016.04.029_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.molcel.2012.05.043","article-title":"Glutaminolysis activates Rag-mTORC1 signaling","volume":"47","author":"Dur\u00e1n","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2016.04.029_bib14","doi-asserted-by":"crossref","first-page":"29083","DOI":"10.1074\/jbc.270.49.29083","article-title":"Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences","volume":"270","author":"Ebert","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2016.04.029_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nrclinonc.2011.21","article-title":"Antiangiogenic therapy: impact on invasion, disease progression, and metastasis","volume":"8","author":"Ebos","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.celrep.2016.04.029_bib16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccr.2009.01.021","article-title":"Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis","volume":"15","author":"Ebos","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2016.04.029_bib17","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1158\/0008-5472.CAN-12-2796","article-title":"Acidity generated by the tumor microenvironment drives local invasion","volume":"73","author":"Estrella","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2016.04.029_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/339058a0","article-title":"Induction of angiogenesis during the transition from hyperplasia to neoplasia","volume":"339","author":"Folkman","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2016.04.029_bib19","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2016.04.029_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ng1197-327","article-title":"Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2","volume":"17","author":"Guillam","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2016.04.029_bib21","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1073\/pnas.1219555110","article-title":"Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma","volume":"110","author":"Guillaumond","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2016.04.029_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/CMAR.S74202","article-title":"Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinoma","volume":"7","author":"Gunnarsson","year":"2015","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.celrep.2016.04.029_bib23","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.celrep.2016.04.015","article-title":"Resistance to antiangiogenic therapies by metabolic symbiosis in renal cell carcinoma PDX models and patients","volume":"15","author":"Jim\u00e9nez-Valerio","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2016.04.029_bib24","doi-asserted-by":"crossref","first-page":"e75154","DOI":"10.1371\/journal.pone.0075154","article-title":"Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer","volume":"8","author":"Kennedy","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.celrep.2016.04.029_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2049-3002-1-23","article-title":"Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress","volume":"1","author":"Lamonte","year":"2013","journal-title":"Cancer Metab."},{"key":"10.1016\/j.celrep.2016.04.029_bib26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2016.04.029_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2217\/cns.12.36","article-title":"Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma","volume":"2","author":"Lu","year":"2013","journal-title":"CNS Oncol."},{"key":"10.1016\/j.celrep.2016.04.029_bib28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.15252\/emmm.201404271","article-title":"Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality","volume":"7","author":"McIntyre","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.celrep.2016.04.029_bib29","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/cncr.26429","article-title":"Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma","volume":"118","author":"Molina","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.celrep.2016.04.029_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/mc.21863","article-title":"Metabolic symbiosis in cancer: refocusing the Warburg lens","volume":"52","author":"Nakajima","year":"2013","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.celrep.2016.04.029_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/1947601909358722","article-title":"Differential contribution to neuroendocrine tumorigenesis of parallel egfr signaling in cancer cells and pericytes","volume":"1","author":"Nolan-Stevaux","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.celrep.2016.04.029_bib32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","article-title":"Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis","volume":"15","author":"P\u00e0ez-Ribes","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2016.04.029_bib33","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1073\/pnas.0501703102","article-title":"The contribution of GABA to glutamate\/glutamine cycling and energy metabolism in the rat cortex in\u00a0vivo","volume":"102","author":"Patel","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2016.04.029_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/15384101.2015.1120930","article-title":"Lactate promotes glutamine uptake and metabolism in oxidative cancer cells","volume":"15","author":"P\u00e9rez-Escuredo","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.celrep.2016.04.029_bib35","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.celrep.2016.04.028","article-title":"Targeting metabolic symbiosis to overcome resistance to anti-angiogenic therapy","volume":"15","author":"Pisarsky","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2016.04.029_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib malate for the treatment of pancreatic neuroendocrine tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2016.04.029_bib37","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.celrep.2014.06.059","article-title":"Role of angiopoietin-2 in adaptive tumor resistance to VEGF signaling blockade","volume":"8","author":"Rigamonti","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2016.04.029_bib38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.celrep.2015.03.055","article-title":"Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy","volume":"11","author":"Rivera","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2016.04.029_bib39","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1128\/MCB.21.10.3436-3444.2001","article-title":"Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells","volume":"21","author":"Seagroves","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.celrep.2016.04.029_bib40","first-page":"3835","article-title":"Tumor metabolism: cancer cells give and take lactate","volume":"118","author":"Semenza","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2016.04.029_bib41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/2159-8290.CD-11-0240","article-title":"Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors","volume":"2","author":"Sennino","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2016.04.029_bib42","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1073\/pnas.96.14.8235","article-title":"Determination of the rate of the glutamate\/glutamine cycle in the human brain by in\u00a0vivo 13C NMR","volume":"96","author":"Shen","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2016.04.029_bib43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.drup.2008.09.001","article-title":"Role of the microenvironment in tumor growth and in refractoriness\/resistance to anti-angiogenic therapies","volume":"11","author":"Shojaei","year":"2008","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.celrep.2016.04.029_bib44","first-page":"3930","article-title":"Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice","volume":"118","author":"Sonveaux","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2016.04.029_bib45","doi-asserted-by":"crossref","first-page":"10791","DOI":"10.1073\/pnas.0914076107","article-title":"Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy","volume":"107","author":"Ulanet","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2016.04.029_bib46","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1074\/jbc.M511397200","article-title":"The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism","volume":"281","author":"Ullah","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2016.04.029_bib47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10456-014-9420-y","article-title":"Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions","volume":"17","author":"Vasudev","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1016\/j.celrep.2016.04.029_bib48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00004647-199801000-00011","article-title":"Metabolism of lactate in cultured GABAergic neurons studied by 13C nuclear magnetic resonance spectroscopy","volume":"18","author":"Waagepetersen","year":"1998","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.celrep.2016.04.029_bib49","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1172\/JCI70212","article-title":"Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer","volume":"123","author":"Welti","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2016.04.029_bib50","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1074\/jbc.M113.543637","article-title":"Simultaneous steady-state and dynamic 13C NMR can differentiate alternative routes of pyruvate metabolism in living cancer cells","volume":"289","author":"Yang","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2016.04.029_bib51","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124716304429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124716304429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:53:52Z","timestamp":1761904432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124716304429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S2211124716304429"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2016.04.029","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726325892.793543333","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2016.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2016.04.028","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2016.04.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors.","name":"copyright","label":"Copyright"}]}}